(Q42830714)

English

Peroxisome proliferator-activated receptor-gamma ligands inhibit adipocyte 11beta -hydroxysteroid dehydrogenase type 1 expression and activity

scientific article published on 22 January 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

8 November 2017

Peroxisome proliferator-activated receptor-gamma ligands inhibit adipocyte 11beta -hydroxysteroid dehydrogenase type 1 expression and activity (English)

1 reference

Europe PubMed Central

8 November 2017

1 reference

based on heuristic

inferred from title

author name string

J Berger

1

1 reference

Europe PubMed Central

8 November 2017

M Tanen

2

1 reference

Europe PubMed Central

8 November 2017

A Elbrecht

3

1 reference

Europe PubMed Central

8 November 2017

A Hermanowski-Vosatka

4

1 reference

Europe PubMed Central

8 November 2017

D E Moller

5

1 reference

Europe PubMed Central

8 November 2017

S D Wright

6

1 reference

Europe PubMed Central

8 November 2017

R Thieringer

7

1 reference

Europe PubMed Central

8 November 2017

language of work or name

0 references

publication date

22 January 2001

1 reference

Europe PubMed Central

8 November 2017

number of pages

7

1 reference

based on heuristic

inferred from page(s)

Journal of Biological Chemistry

1 reference

Europe PubMed Central

8 November 2017

276

1 reference

Europe PubMed Central

8 November 2017

12629-12635

1 reference

Europe PubMed Central

8 November 2017

16

1 reference

Europe PubMed Central

8 November 2017

Visceral fat accumulation: the missing link between psychosocial factors and cardiovascular disease?

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M003592200

21 January 2018

PPARgamma: an essential regulator of adipogenesis and modulator of fat cell function

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M003592200

21 January 2018

Glucocorticoid regulation of adipocyte differentiation: hormonal triggering of the developmental program and induction of a differentiation-dependent gene

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M003592200

21 January 2018

Hormonal control of adipogenesis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M003592200

21 January 2018

Promoting effect of glucocorticoids on the differentiation of human adipocyte precursor cells cultured in a chemically defined medium

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M003592200

21 January 2018

Muscle and adipose tissue morphology and metabolism in Cushing's syndrome.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M003592200

21 January 2018

Hypercortisolism and obesity

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M003592200

21 January 2018

Does central obesity reflect "Cushing's disease of the omentum"?

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M003592200

21 January 2018

11beta-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M003592200

21 January 2018

Glucocorticoids and insulin resistance: old hormones, new targets

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M003592200

21 January 2018

Peroxisome proliterator-activated receptors, orphans with ligands and functions

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M003592200

21 January 2018

Peroxisome proliferator-activated receptors A link between endocrinology and nutrition?

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M003592200

21 January 2018

Differential expression and activation of a family of murine peroxisome proliferator-activated receptors

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M003592200

21 January 2018

Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M003592200

21 January 2018

Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M003592200

21 January 2018

A gender-related defect in lipid metabolism and glucose homeostasis in peroxisome proliferator- activated receptor alpha- deficient mice.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M003592200

21 January 2018

Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M003592200

21 January 2018

Chromosomal localisation, inducibility, tissue-specific expression and strain differences in three murine peroxisome-proliferator-activated-receptor genes.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M003592200

21 January 2018

Rat PPAR delta contains a CGG triplet repeat and is prominently expressed in the thalamic nuclei

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M003592200

21 January 2018

mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M003592200

21 January 2018

Molecular cloning, expression and characterization of human peroxisome proliferator activated receptors gamma 1 and gamma 2

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M003592200

21 January 2018

Structural organization of mouse peroxisome proliferator-activated receptor gamma (mPPAR gamma) gene: alternative promoter use and different splicing yield two mPPAR gamma isoforms

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M003592200

21 January 2018

Differential activation of adipogenesis by multiple PPAR isoforms.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M003592200

21 January 2018

Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M003592200

21 January 2018

PPARγ Is Required for the Differentiation of Adipose Tissue In Vivo and In Vitro

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M003592200

21 January 2018

PPAR gamma is required for placental, cardiac, and adipose tissue development

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M003592200

21 January 2018

PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M003592200

21 January 2018

Improved insulin-sensitivity in mice heterozygous for PPAR-gamma deficiency

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M003592200

21 January 2018

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M003592200

21 January 2018

Novel peroxisome proliferator-activated receptor (PPAR) gamma and PPARdelta ligands produce distinct biological effects

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M003592200

21 January 2018

PPAR gamma 2 regulates adipose expression of the phosphoenolpyruvate carboxykinase gene

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M003592200

21 January 2018

Antidiabetic thiazolidinediones inhibit leptin (ob) gene expression in 3T3-L1 adipocytes

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M003592200

21 January 2018

Functional antagonism between CCAAT/Enhancer binding protein-alpha and peroxisome proliferator-activated receptor-gamma on the leptin promoter

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M003592200

21 January 2018

11Beta-hydroxysteroid dehydrogenase 1 in adipocytes: expression is differentiation-dependent and hormonally regulated

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M003592200

21 January 2018

Negative regulation of peroxisome proliferator-activated receptor-gamma gene expression contributes to the antiadipogenic effects of tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M003592200

21 January 2018

Effects of troglitazone on fat distribution in the treatment of male type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M003592200

21 January 2018

Carbenoxolone increases hepatic insulin sensitivity in man: a novel role for 11-oxosteroid reductase in enhancing glucocorticoid receptor activation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M003592200

21 January 2018

Increased feeding in fatty Zucker rats by the thiazolidinedione BRL 49653 (rosiglitazone) and the possible involvement of leptin and hypothalamic neuropeptide Y.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M003592200

21 January 2018

PPARalpha agonists reduce 11beta-hydroxysteroid dehydrogenase type 1 in the liver.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M003592200

21 January 2018

Identifiers

10.1074/JBC.M003592200

1 reference

Europe PubMed Central

8 November 2017

1 reference

Europe PubMed Central

8 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42830714&oldid=1971497866"